These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Regulation of the human cyclin C gene via multiple vitamin D3-responsive regions in its promoter. Sinkkonen L, Malinen M, Saavalainen K, Väisänen S, Carlberg C. Nucleic Acids Res; 2005; 33(8):2440-51. PubMed ID: 15863722 [Abstract] [Full Text] [Related]
3. Controlling the chromatin organization of vitamin D target genes by multiple vitamin D receptor binding sites. Carlberg C, Dunlop TW, Saramäki A, Sinkkonen L, Matilainen M, Väisänen S. J Steroid Biochem Mol Biol; 2007 Mar; 103(3-5):338-43. PubMed ID: 17234401 [Abstract] [Full Text] [Related]
7. Regulation of the human p21(waf1/cip1) gene promoter via multiple binding sites for p53 and the vitamin D3 receptor. Saramäki A, Banwell CM, Campbell MJ, Carlberg C. Nucleic Acids Res; 2006 Feb; 34(2):543-54. PubMed ID: 16434701 [Abstract] [Full Text] [Related]
8. The human transient receptor potential vanilloid type 6 distal promoter contains multiple vitamin D receptor binding sites that mediate activation by 1,25-dihydroxyvitamin D3 in intestinal cells. Meyer MB, Watanuki M, Kim S, Shevde NK, Pike JW. Mol Endocrinol; 2006 Jun; 20(6):1447-61. PubMed ID: 16574738 [Abstract] [Full Text] [Related]
10. Regulation of multiple insulin-like growth factor binding protein genes by 1alpha,25-dihydroxyvitamin D3. Matilainen M, Malinen M, Saavalainen K, Carlberg C. Nucleic Acids Res; 2005 Jun; 33(17):5521-32. PubMed ID: 16186133 [Abstract] [Full Text] [Related]
11. Thyroid hormone receptor does not heterodimerize with the vitamin D receptor but represses vitamin D receptor-mediated transactivation. Raval-Pandya M, Freedman LP, Li H, Christakos S. Mol Endocrinol; 1998 Sep; 12(9):1367-79. PubMed ID: 9731705 [Abstract] [Full Text] [Related]
13. The vitamin D hormone and its nuclear receptor: molecular actions and disease states. Haussler MR, Haussler CA, Jurutka PW, Thompson PD, Hsieh JC, Remus LS, Selznick SH, Whitfield GK. J Endocrinol; 1997 Sep; 154 Suppl():S57-73. PubMed ID: 9379138 [Abstract] [Full Text] [Related]
14. Antagonistic action of novel 1alpha,25-dihydroxyvitamin D3-26, 23-lactone analogs on differentiation of human leukemia cells (HL-60) induced by 1alpha,25-dihydroxyvitamin D3. Miura D, Manabe K, Ozono K, Saito M, Gao Q, Norman AW, Ishizuka S. J Biol Chem; 1999 Jun 04; 274(23):16392-9. PubMed ID: 10347199 [Abstract] [Full Text] [Related]
17. Evidence for 1,25-dihydroxyvitamin D3-independent transactivation by the vitamin D receptor: uncoupling the receptor and ligand in keratinocytes. Ellison TI, Eckert RL, MacDonald PN. J Biol Chem; 2007 Apr 13; 282(15):10953-62. PubMed ID: 17310066 [Abstract] [Full Text] [Related]
18. Calcitriol upregulates open chromatin and elongation markers at functional vitamin D response elements in the distal part of the 5-lipoxygenase gene. Stoffers KL, Sorg BL, Seuter S, Rau O, Rådmark O, Steinhilber D. J Mol Biol; 2010 Jan 29; 395(4):884-96. PubMed ID: 19837082 [Abstract] [Full Text] [Related]
19. Identification of a functional vitamin D response element in the human insulin-like growth factor binding protein-3 promoter. Peng L, Malloy PJ, Feldman D. Mol Endocrinol; 2004 May 29; 18(5):1109-19. PubMed ID: 14963110 [Abstract] [Full Text] [Related]